Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (5): 489-492.DOI: 10.3969/j.issn.1673-8640.2022.05.018

• Original article • Previous Articles     Next Articles

Research progress of methicillin-resistant Staphylococcus aureus screening and decolonization to reduce surgical site infection

TANG Jin1, PAN Yunqi1, YANG Yumei2, WU Qiong1, WANG Jianqiang1, LI Yungai1, DI Jianzhong3()   

  1. 1. Department of Clinical Laboratory,Shanghai Sixth People's Hospital,Shanghai 200233,China
    2. Department of Hospital Infection-Control,Shanghai Sixth People's Hospital,Shanghai 200233,China
    3. Office of Director of Hospital,Shanghai Sixth People's Hospital,Shanghai 200233,China
  • Received:2020-05-01 Revised:2021-06-12 Online:2022-05-30 Published:2022-07-20
  • Contact: DI Jianzhong

Abstract:

Surgical site infection is one of the most common healthcare-associated infections. Staphylococcus aureus remains the most common etiologic agent causing surgical site infection. The colonization of methicillin-resistant Staphylococcus aureus(MRSA) increases the risk of surgical site infection. Screening and decolonization of MRSA can reduce the rates of surgical site infection. The purpose of this review is to summarize the strategies to reduce surgical site infection due to MRSA focusing on decolonization.

Key words: Methicillin-resistant Staphylococcus aureus, Staphylococcus aureus, Colonization, Surgical site infection